Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
about
Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium.Growth inhibitory actions of prothrombin on normal hepatocytes: influence of matrix.Performance of Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) for Hepatocellular Carcinoma Screening in Chinese Population.A young woman with liver cancer.Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients.
P2860
Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
description
1991 nî lūn-bûn
@nan
1991 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
@ast
Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
@en
Abnormal prothrombin
@nl
type
label
Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
@ast
Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
@en
Abnormal prothrombin
@nl
prefLabel
Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
@ast
Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma.
@en
Abnormal prothrombin
@nl
P2093
P2860
P1476
Abnormal prothrombin (DES-gamma-carboxy prothrombin) in hepatocellular carcinoma
@en
P2093
P2860
P304
P577
1991-10-01T00:00:00Z